Infliximab Weakens COVID Antibody Response for Patients With IBD
Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated
Read more
Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated
Read moreMore sleep at night, fewer or no sleep problems, and low levels of professional burnout were associated with a lower
Read more